In close collaboration with KALADENT AG St. Gallen, marcs group AG exclusively represents  OsteoBiol® Biomaterials for guided tissue / bone regeneration (GBR / GTR) in Switzerland. These collagenated biomaterials are developed and produced by TECNOSS / IT-Torino.

We are happy to provide more detailled information - just send us an e-mail at info@marcs-group.com or check the specific links on Biomaterials.

TECNOSS DENTAL was created to distribute the innovative OsteoBiol® product line worldwide. OsteoBiol® is the most complete range of collagenated xenografts available on the market today: this new generation of biomaterials, thanks to a revolutionary technologic process which neutralizes the antigenic components present in heterologous bone (achievement of biocompatibility), goes beyond the simple role of aiding natural bone regrowth by stimulating and accelerating this physiological process. Providing a specific product for every specific need is our mission: customer and patient satisfaction our commitment.

Research
TENOSS strongly believes in evidence-based medicine: a considerable share of the resources is dedicated to the developement of new materials while constantly monitoring clinical results of existing products.

Clinical research is another focus: TECNOSS cooperates with several public and private research centers in order to improve clinical outcome scientific evidence of OsteBiol grafting materials. Several studies have already been published on international scientific journals, and new research protocols are in progress.